Evofem Biosciences, Inc. (EVFM) › Cost of RevenueEvofem Biosciences, Inc. (EVFM) — Cost of RevenueAnnual figures by period end, from SEC filings.2019-12-31: $02020-12-31: $468.0K2021-12-31: $4.05M2022-12-31: $4.42M2023-12-31: $6.51M2024-12-31: $3.83M2025-12-31: $4.62M$4.62M2019-12-31Cost of Revenue (USD)2025-12-31Period endedCost of RevenueChange YoYSource filing2025-12-31$4.62M+20.4%2026-03-11From 2025-01-012024-12-31$3.83M-41.1%2026-03-11From 2024-01-012023-12-31$6.51M+47.5%2025-03-24From 2023-01-012022-12-31$4.42M+8.9%2024-03-27From 2022-01-012021-12-31$4.05M+766.5%2023-04-27From 2021-01-012020-12-31$468.0K—2022-03-10From 2020-01-012019-12-31$0—2021-03-04From 2019-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)